Clinical trial
A Multicenter, Prospective, Longitudinal Study to Assess Real-World Use and Outcomes After the Launch of TAR-200 for NMIBC in the US
NCT07309445 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Longitudinal Study to Assess Real-World Use and Outcomes After the Launch of TAR-200 for NMIBC in the US
- Lead sponsor
- Janssen Research & Development, LLC
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 12, 2026
- Completion date
- June 28, 2030
- Enrollment
- 150 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.